Efferocytosis in Health and Disease

Area of Science:

• Immunology
• Cell Biology
• Pathophysiology

Background:

• Efferocytosis is vital for tissue homeostasis, immune tolerance, and repair.
• Dysregulation of efferocytosis contributes to chronic inflammation and impaired regeneration.
• Existing research lacks a unified framework integrating efferocytosis across diverse diseases.

Purpose of the Study:

• To provide a comprehensive overview of efferocytosis biology.
• To highlight disease-specific alterations in efferocytosis.
• To summarize emerging therapeutic and monitoring strategies.

Main Methods:

• Literature review of efferocytosis mechanisms and disease contexts.
• Analysis of regulatory networks including signals, receptors, and metabolic checkpoints.
• Synthesis of current and emerging therapeutic interventions.

Main Results:

• Efferocytosis involves complex regulatory networks (signals, receptors, signaling, metabolism).
• Disease-specific alterations in atherosclerosis, myocardial infarction, autoimmune diseases, neuroinflammation, and cancer are identified.
• Emerging therapies include receptor agonists, metabolic interventions, and immune modulation.

Conclusions:

• A unified framework for efferocytosis is needed.
• Targeting efferocytosis offers therapeutic potential across multiple diseases.
• A 'full-cycle' monitoring strategy integrating advanced technologies is proposed.